HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

Clinical trials for HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA explained in plain language.

Never miss a new study

Get alerted when new HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA trials appear

Sign up with your email to follow new studies for HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Teens with genetic cholesterol disorder tracked for long-term drug safety

Disease control Ongoing

This study follows teenagers with a genetic condition causing very high cholesterol (familial hypercholesterolemia) who previously took the drug inclisiran in earlier trials. The main goal is to monitor the long-term safety and side effects of continued treatment. It also provide…

Matched conditions: HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

Get alerted when new HETEROZYGOUS OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA trials appear

Teens with genetic cholesterol disorder tracked for long-term drug safety